ICICI Direct is bullish on GSK Consumer has recommended buy rating on the stock with a target price of Rs 8000 in its research report dated November 05, 2018.
ICICI Direct's research report on GSK Consumer
Strong volume growth of 13.7% led to 14.4% increase in Q2FY19 sales to Rs 1,272 crore. Export revenues swelled by 74% on account of addition of Malaysia in the export market. The domestic business grew 10.8% on account of domestic volume growth of 8.7% Auxiliary income increased 20% YoY on the back of an improvement in OTC products and oral care portfolio performance. Volume market share of Horlicks was 49.5% with value market share of 43.3%. On the other hand, volume market share of Boost was 13.9% with value market share of 10.9% Benefitted by low input costs, especially milk prices, EBITDA margins surged 451 bps to 27.8% primarily driven by a 510 bps increase in gross margins, partly offset by higher employee expenses & other overheads during the quarter. With higher operating profit and other income, PAT for the quarter increased 43.2% YoY to Rs 275.5 crore.
We reiterate our BUY recommendation on the stock with a revised target price of Rs 8,000/share, 36x FY20E earnings.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.